Several reports have indicated that in various cancers and tumors, including lung cancer, colorectal cancer, and serrated adenomas, SYNE1 expression is epigenetically repressed through hypermethylation of the CpG island, residing in either the promoter or coding region [32,33,34]. The gene discussed is SYNE1; the disease is lung carcinoma.